203 related articles for article (PubMed ID: 22729867)
41. MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.
Yacoub A; Mitchell C; Hong Y; Gopalkrishnan RV; Su ZZ; Gupta P; Sauane M; Lebedeva IV; Curiel DT; Mahasreshti PJ; Rosenfeld MR; Broaddus WC; James CD; Grant S; Fisher PB; Dent P
Cancer Biol Ther; 2004 Aug; 3(8):739-51. PubMed ID: 15197348
[TBL] [Abstract][Full Text] [Related]
42. A novel regulatory role of RGS4 in STAT5B activation, neurite outgrowth and neuronal differentiation.
Pallaki P; Georganta EM; Serafimidis I; Papakonstantinou MP; Papanikolaou V; Koutloglou S; Papadimitriou E; Agalou A; Tserga A; Simeonof A; Thomaidou D; Gaitanou M; Georgoussi Z
Neuropharmacology; 2017 May; 117():408-421. PubMed ID: 28219718
[TBL] [Abstract][Full Text] [Related]
43. SHP-2-dependent mitogen-activated protein kinase activation regulates EGFRvIII but not wild-type epidermal growth factor receptor phosphorylation and glioblastoma cell survival.
Zhan Y; O'Rourke DM
Cancer Res; 2004 Nov; 64(22):8292-8. PubMed ID: 15548697
[TBL] [Abstract][Full Text] [Related]
44. STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor.
Kloth MT; Laughlin KK; Biscardi JS; Boerner JL; Parsons SJ; Silva CM
J Biol Chem; 2003 Jan; 278(3):1671-9. PubMed ID: 12429742
[TBL] [Abstract][Full Text] [Related]
45. Activation of STAT5 contributes to proliferation in U87 human glioblastoma multiforme cells.
Feng C; Cao S
Mol Med Rep; 2014 Jul; 10(1):203-10. PubMed ID: 24821382
[TBL] [Abstract][Full Text] [Related]
46. A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapy.
Huang X; Zhang Y; Tang Y; Butler N; Kim J; Guessous F; Schiff D; Mandell J; Abounader R
Neoplasia; 2013 Aug; 15(8):952-65. PubMed ID: 23908595
[TBL] [Abstract][Full Text] [Related]
47. DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome.
Televantou D; Karkavelas G; Hytiroglou P; Lampaki S; Iliadis G; Selviaridis P; Polyzoidis KS; Fountzilas G; Kotoula V
Pathol Oncol Res; 2013 Apr; 19(2):329-43. PubMed ID: 23250732
[TBL] [Abstract][Full Text] [Related]
48. Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma.
Zhang Y; Kim J; Mueller AC; Dey B; Yang Y; Lee DH; Hachmann J; Finderle S; Park DM; Christensen J; Schiff D; Purow B; Dutta A; Abounader R
Cell Death Differ; 2014 May; 21(5):720-34. PubMed ID: 24440911
[TBL] [Abstract][Full Text] [Related]
49. Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFR
von Achenbach C; Silginer M; Blot V; Weiss WA; Weller M
Mol Cancer Ther; 2020 Jun; 19(6):1328-1339. PubMed ID: 32371586
[TBL] [Abstract][Full Text] [Related]
50. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
[TBL] [Abstract][Full Text] [Related]
51. ZD6474, a multitargeted inhibitor for receptor tyrosine kinases, suppresses growth of gliomas expressing an epidermal growth factor receptor mutant, EGFRvIII, in the brain.
Yiin JJ; Hu B; Schornack PA; Sengar RS; Liu KW; Feng H; Lieberman FS; Chiou SH; Sarkaria JN; Wiener EC; Ma HI; Cheng SY
Mol Cancer Ther; 2010 Apr; 9(4):929-41. PubMed ID: 20371720
[TBL] [Abstract][Full Text] [Related]
52. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.
Nagane M; Coufal F; Lin H; Bögler O; Cavenee WK; Huang HJ
Cancer Res; 1996 Nov; 56(21):5079-86. PubMed ID: 8895767
[TBL] [Abstract][Full Text] [Related]
53. JAK2/STAT5/Bcl-xL signalling is essential for erythropoietin-mediated protection against apoptosis induced in PC12 cells by the amyloid β-peptide Aβ25-35.
Ma R; Hu J; Huang C; Wang M; Xiang J; Li G
Br J Pharmacol; 2014 Jul; 171(13):3234-45. PubMed ID: 24597613
[TBL] [Abstract][Full Text] [Related]
54. The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cells.
Estrada-Bernal A; Lawler SE; Nowicki MO; Ray Chaudhury A; Van Brocklyn JR
J Neurooncol; 2011 May; 102(3):353-66. PubMed ID: 20938717
[TBL] [Abstract][Full Text] [Related]
55. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
Nieborowska-Skorska M; Wasik MA; Slupianek A; Salomoni P; Kitamura T; Calabretta B; Skorski T
J Exp Med; 1999 Apr; 189(8):1229-42. PubMed ID: 10209040
[TBL] [Abstract][Full Text] [Related]
56. A novel role of CPEB3 in regulating EGFR gene transcription via association with Stat5b in neurons.
Peng SC; Lai YT; Huang HY; Huang HD; Huang YS
Nucleic Acids Res; 2010 Nov; 38(21):7446-57. PubMed ID: 20639532
[TBL] [Abstract][Full Text] [Related]
57. Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ.
Schulte A; Liffers K; Kathagen A; Riethdorf S; Zapf S; Merlo A; Kolbe K; Westphal M; Lamszus K
Neuro Oncol; 2013 Oct; 15(10):1289-301. PubMed ID: 23877316
[TBL] [Abstract][Full Text] [Related]
58. A novel EGFR variant EGFRx maintains glioblastoma stem cells through STAT5.
Huang W; Li J; Zhu H; Qin X; Chen C; Wang B; Wei J; Song Y; Lu X; Li Z; Xia W; He A; Cheng L; Yu X; Shu K; Wang W
Neuro Oncol; 2024 Jan; 26(1):85-99. PubMed ID: 37616578
[TBL] [Abstract][Full Text] [Related]
59. EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
Nalluri S; Peirce SK; Tanos R; Abdella HA; Karmali D; Hogarty MD; Goldsmith KC
Cancer Biol Ther; 2015; 16(2):276-86. PubMed ID: 25756510
[TBL] [Abstract][Full Text] [Related]
60. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.
Inda MM; Bonavia R; Mukasa A; Narita Y; Sah DW; Vandenberg S; Brennan C; Johns TG; Bachoo R; Hadwiger P; Tan P; Depinho RA; Cavenee W; Furnari F
Genes Dev; 2010 Aug; 24(16):1731-45. PubMed ID: 20713517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]